Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-21

Clinical Trial Update: Trauma Resuscitation With Low-Titer Group O Whole Blood or Products [Phase 3]

View source ↗

Summary

Phase 3 trial update on trauma resuscitation using low-titer Group O whole blood or related products in patients with wounds, injuries, and hemorrhagic shock; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low-titer Group O whole blood (low-titer Group O whole blood)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Wounds and Injuries, Shock, Hemorrhagic | Phase 3 | Status: RECRUITING